vs
ASTEC INDUSTRIES INC（ASTE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
ASTEC INDUSTRIES INC的季度营收约是Orthofix Medical Inc.的1.8倍（$400.6M vs $219.9M），ASTEC INDUSTRIES INC净利率更高（3.0% vs -1.0%，领先4.0%），ASTEC INDUSTRIES INC同比增速更快（11.6% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $7.4M），过去两年ASTEC INDUSTRIES INC的营收复合增速更高（13.8% vs 8.0%）
ASTEC是一家国际电子企业，原总部设于香港，主营电源供应装置与电力转换硬件产品，是全球计算机系统电源的主要供应商之一，曾一度是全球规模最大的电源生产商。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ASTE vs OFIX — 直观对比
营收规模更大
ASTE
是对方的1.8倍
$219.9M
营收增速更快
ASTE
高出9.6%
2.0%
净利率更高
ASTE
高出4.0%
-1.0%
自由现金流更多
OFIX
多$9.4M
$7.4M
两年增速更快
ASTE
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $400.6M | $219.9M |
| 净利润 | $12.0M | $-2.2M |
| 毛利率 | 27.3% | 71.1% |
| 营业利润率 | 5.7% | 0.2% |
| 净利率 | 3.0% | -1.0% |
| 营收同比 | 11.6% | 2.0% |
| 净利润同比 | -43.1% | 92.4% |
| 每股收益（稀释后） | $0.52 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTEOFIX
| Q4 25 | $400.6M | $219.9M | ||
| Q3 25 | $350.1M | $205.6M | ||
| Q2 25 | $330.3M | $203.1M | ||
| Q1 25 | $329.4M | $193.6M | ||
| Q4 24 | $359.0M | $215.7M | ||
| Q3 24 | $291.4M | $196.6M | ||
| Q2 24 | $345.5M | $198.6M | ||
| Q1 24 | $309.2M | $188.6M |
净利润ASTEOFIX
| Q4 25 | $12.0M | $-2.2M | ||
| Q3 25 | $-4.2M | $-22.8M | ||
| Q2 25 | $16.7M | $-14.1M | ||
| Q1 25 | $14.3M | $-53.1M | ||
| Q4 24 | $21.1M | $-29.1M | ||
| Q3 24 | $-6.2M | $-27.4M | ||
| Q2 24 | $-14.0M | $-33.4M | ||
| Q1 24 | $3.4M | $-36.0M |
毛利率ASTEOFIX
| Q4 25 | 27.3% | 71.1% | ||
| Q3 25 | 24.1% | 72.2% | ||
| Q2 25 | 26.7% | 68.7% | ||
| Q1 25 | 28.1% | 62.8% | ||
| Q4 24 | 28.7% | 69.0% | ||
| Q3 24 | 22.9% | 68.7% | ||
| Q2 24 | 23.5% | 67.8% | ||
| Q1 24 | 24.9% | 67.5% |
营业利润率ASTEOFIX
| Q4 25 | 5.7% | 0.2% | ||
| Q3 25 | 0.3% | -8.3% | ||
| Q2 25 | 6.5% | -7.9% | ||
| Q1 25 | 6.2% | -25.2% | ||
| Q4 24 | 9.7% | -5.3% | ||
| Q3 24 | -2.5% | -9.6% | ||
| Q2 24 | -3.1% | -12.5% | ||
| Q1 24 | 2.0% | -15.6% |
净利率ASTEOFIX
| Q4 25 | 3.0% | -1.0% | ||
| Q3 25 | -1.2% | -11.1% | ||
| Q2 25 | 5.1% | -6.9% | ||
| Q1 25 | 4.3% | -27.4% | ||
| Q4 24 | 5.9% | -13.5% | ||
| Q3 24 | -2.1% | -13.9% | ||
| Q2 24 | -4.1% | -16.8% | ||
| Q1 24 | 1.1% | -19.1% |
每股收益（稀释后）ASTEOFIX
| Q4 25 | $0.52 | $-0.05 | ||
| Q3 25 | $-0.18 | $-0.57 | ||
| Q2 25 | $0.72 | $-0.36 | ||
| Q1 25 | $0.62 | $-1.35 | ||
| Q4 24 | $0.92 | $-0.76 | ||
| Q3 24 | $-0.27 | $-0.71 | ||
| Q2 24 | $-0.61 | $-0.88 | ||
| Q1 24 | $0.15 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.1M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $681.7M | $450.0M |
| 总资产 | $1.4B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTEOFIX
| Q4 25 | $74.1M | $82.0M | ||
| Q3 25 | $71.8M | $62.9M | ||
| Q2 25 | $91.6M | $65.6M | ||
| Q1 25 | $95.4M | $58.0M | ||
| Q4 24 | $93.8M | $83.2M | ||
| Q3 24 | $58.9M | $30.1M | ||
| Q2 24 | $68.4M | $26.4M | ||
| Q1 24 | $63.8M | $27.0M |
总债务ASTEOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ASTEOFIX
| Q4 25 | $681.7M | $450.0M | ||
| Q3 25 | $668.9M | $442.5M | ||
| Q2 25 | $674.9M | $458.3M | ||
| Q1 25 | $653.2M | $458.3M | ||
| Q4 24 | $637.8M | $503.1M | ||
| Q3 24 | $631.4M | $525.9M | ||
| Q2 24 | $633.3M | $546.0M | ||
| Q1 24 | $650.3M | $570.3M |
总资产ASTEOFIX
| Q4 25 | $1.4B | $850.6M | ||
| Q3 25 | $1.3B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.1B | $823.1M | ||
| Q4 24 | $1.0B | $893.3M | ||
| Q3 24 | $1.1B | $867.9M | ||
| Q2 24 | $1.1B | $882.0M | ||
| Q1 24 | $1.1B | $906.0M |
负债/权益比ASTEOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $7.4M | $16.8M |
| 自由现金流率自由现金流/营收 | 1.8% | 7.6% |
| 资本支出强度资本支出/营收 | 7.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.01× | — |
| 过去12个月自由现金流最近4个季度 | $20.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ASTEOFIX
| Q4 25 | $36.1M | $27.7M | ||
| Q3 25 | $-8.1M | $12.4M | ||
| Q2 25 | $12.9M | $11.6M | ||
| Q1 25 | $20.5M | $-18.4M | ||
| Q4 24 | $36.6M | $23.7M | ||
| Q3 24 | $22.5M | $11.7M | ||
| Q2 24 | $10.9M | $9.0M | ||
| Q1 24 | $-47.0M | $-18.6M |
自由现金流ASTEOFIX
| Q4 25 | $7.4M | $16.8M | ||
| Q3 25 | $-12.3M | $2.5M | ||
| Q2 25 | $9.0M | $4.5M | ||
| Q1 25 | $16.6M | $-25.1M | ||
| Q4 24 | $32.1M | $15.2M | ||
| Q3 24 | $19.9M | $6.3M | ||
| Q2 24 | $3.3M | $-360.0K | ||
| Q1 24 | $-52.8M | $-29.1M |
自由现金流率ASTEOFIX
| Q4 25 | 1.8% | 7.6% | ||
| Q3 25 | -3.5% | 1.2% | ||
| Q2 25 | 2.7% | 2.2% | ||
| Q1 25 | 5.0% | -13.0% | ||
| Q4 24 | 8.9% | 7.0% | ||
| Q3 24 | 6.8% | 3.2% | ||
| Q2 24 | 1.0% | -0.2% | ||
| Q1 24 | -17.1% | -15.4% |
资本支出强度ASTEOFIX
| Q4 25 | 7.2% | 4.9% | ||
| Q3 25 | 1.2% | 4.8% | ||
| Q2 25 | 1.2% | 3.5% | ||
| Q1 25 | 1.2% | 3.5% | ||
| Q4 24 | 1.3% | 4.0% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 2.2% | 4.7% | ||
| Q1 24 | 1.9% | 5.6% |
现金转化率ASTEOFIX
| Q4 25 | 3.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 1.43× | — | ||
| Q4 24 | 1.73× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -13.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTE
| Infrastructure Group | $208.7M | 52% |
| Material Solutions | $105.3M | 26% |
| Parts And Component Sales | $58.3M | 15% |
| Other | $15.3M | 4% |
| Service And Equipment Installation Revenue | $6.9M | 2% |
| Cargo And Freight | $6.1M | 2% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
